Literature DB >> 10333513

Blood pressure regulation during hypotension in two teleost species: differential involvement of the renin-angiotensin and adrenergic systems

.   

Abstract

The stimulatory effects of angiotensin II (Ang II) on catecholamine release and the contributions of the renin-angiotensin system, humoral catecholamines and adrenergic nerves to blood pressure regulation were investigated in rainbow trout (Oncorhynchus mykiss) and American eel (Anguilla rostrata). In trout, bolus injections of homologous [Asn1,Val5]-Ang II (100 or 500 pmol kg-1) increased catecholamine secretion rates and plasma catecholamine concentrations from in situ posterior cardinal vein preparations and chronically cannulated fish, respectively. In contrast, in situ or in vivo injections of similar doses of Ang II in eel did not affect catecholamine release. &agr; -Adrenoceptor blockade (prazosin; 1 mg kg-1) reduced the pressor effect of exogenous Ang II (500 pmol kg-1) in both species. In eel, intravenous injection of the smooth muscle relaxant papaverine (10 mg kg-1) elicited a rapid decrease in dorsal aortic pressure (PDA; 58 %) followed by a gradual recovery back to the baseline value 85 min after the treatment. In trout, papaverine elicited a similar decrease in blood pressure (62 %); however, PDA recovered fully 20 min after treatment. Blockade of either &agr; -adrenoceptors with prazosin or adrenergic nerves with bretylium (10 mg kg-1) prior to papaverine treatment did not alter PDA recovery in eel. In trout, &agr; -adrenoceptor and adrenergic nerve blockade prior to the papaverine treatment prevented and attenuated PDA recovery, respectively. In both species, papaverine treatment elicited significant increases in plasma catecholamine and Ang II concentrations. However, the increases in plasma catecholamine concentrations were markedly greater in trout than in eel. Similarly, the papaverine-elicited increase in plasma Ang II levels occurred earlier and was greater in trout than in eel. Thus, while Ang II stimulates humoral catecholamine release in trout, there is no evidence for a similar interaction in eel. Moreover, during hypotensive stress, although the renin-angiotensin system is recruited in both species, an essential involvement of adrenergic nerves and humoral catecholamines in the restoration of blood pressure is only apparent in trout.

Entities:  

Year:  1999        PMID: 10333513     DOI: 10.1242/jeb.202.12.1677

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  6 in total

1.  Cardiovascular responses of three salmonid species affected with amoebic gill disease (AGD).

Authors:  M J Leef; J O Harris; J Hill; M D Powell
Journal:  J Comp Physiol B       Date:  2005-10-26       Impact factor: 2.200

2.  Stanniectomy attenuates the renin-angiotensin response to hypovolemic hypotension in freshwater eels (Anguilla rostrata) but not blood pressure recovery.

Authors:  David Gordon Butler; Judith Anne Brown
Journal:  J Comp Physiol B       Date:  2006-10-25       Impact factor: 2.200

3.  Circulatory function at sub-zero temperature: venous responses to catecholamines and angiotensin II in the Antarctic fish Pagothenia borchgrevinki.

Authors:  Erik Sandblom; Michael Axelsson; William Davison
Journal:  J Comp Physiol B       Date:  2008-10-22       Impact factor: 2.200

4.  Cold physiology: postprandial blood flow dynamics and metabolism in the Antarctic fish Pagothenia borchgrevinki.

Authors:  Erik Sandblom; William Davison; Michael Axelsson
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

5.  Brain neuropeptides in central ventilatory and cardiovascular regulation in trout.

Authors:  Jean-Claude Le Mével; Frédéric Lancien; Nagi Mimassi; J Michael Conlon
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

Review 6.  Osmoregulation in zebrafish: ion transport mechanisms and functional regulation.

Authors:  Ying-Jey Guh; Chia-Hao Lin; Pung-Pung Hwang
Journal:  EXCLI J       Date:  2015-05-11       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.